Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3825-3833

  Bourne, C R ^a   Barrow, E W ^a   Bunce, R A ^a   Bourne, P C ^a   Berlin, K D ^a   Barrow, W W ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DIHYDROFOLATE REDUCTASE; DIHYDROFOLATE REDUCTASE INHIBITOR; ICLAPRIM; PHTHALAZINE DERIVATIVE; RAB 1; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG EFFICACY; DRUG STRUCTURE; ENANTIOMER; IC 50; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; WILD TYPE;

ANTI-BACTERIAL AGENTS; ENZYME INHIBITORS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; STAPHYLOCOCCUS AUREUS; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 77956107320     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00361-10     Document Type: Article

References (33)

1. Adams, P. D., P. V. Afonine, G. Bunkoczi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L. W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W. Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C. Terwilliger, and P. H. Zwart. 2010. PHENIX: a comprehensive Pythonbased system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66:213-221.
2. Barrow, E. W., P. C. Bourne, and W. W. Barrow. 2004. Functional cloning of Bacillus anthracis DHFR and confirmation of natural resistance to trimethoprim. Antimicrob. Agents Chemother. 48:4643-4649.
3. Barrow, E. W., J. Dreier, S. Reinelt, P. C. Bourne, and W. W. Barrow. 2007. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis. Antimicrob. Agents Chemother. 51:4447-4452.
4. Bourne, C. R., R. A. Bunce, P. C. Bourne, K. D. Berlin, E. W. Barrow, and W. W. Barrow. 2009. Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity. Antimicrob. Agents Chemother. 53:3065-3073.
5. Bunce, R. A., C. R. Bourne, P. C. Bourne, E. W. Barrow, W. W. Barrow, and K. D. Berlin. 2009. HPLC detection and enantiomeric separation of (+)- and (-)-(E)-3-[5-(2,4-diaminopyrimidin-5-ylmethyl)-2,3-dimethoxyphenyl] -1-(1-propyl-1H-phthalazin-2-yl)propenone, inhibitors of Bacillus anthracis dihydrofolate reductase, by supercritical fluid chromatography. Proc. Okla. Acad. Sci. 89:87-90.
6. Burchall, J. J. 1973. Mechanism of action of trimethoprim- sulfamethoxazole. II. J. Infect. Dis. 128(Suppl.):437-441.
7. Caspers, P., L. Bury, B. Gaucher, J. Heim, S. Shapiro, S. Siegrist, A. Schmitt-Hoffmann, L. Thenoz, and H. Urwyler. 2009. In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugs. Antimicrob. Agents Chemother. 53:3620-3627.
8. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108.
9. Clark, C., L. M. Ednie, G. Lin, K. Smith, K. Kosowska-Shick, P. McGhee, B. Dewasse, L. Beachel, P. Caspers, B. Gaucher, G. Mert, S. Shapiro, and P. C. Appelbaum. 2009. Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs. Antimicrob. Agents Chemother. 53:1353-1361.
10. CLSI. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed., vol. 29. Clinical Laboratory Standards Institute, Wayne, PA.
11. CLSI. 2010. Performance standards for antimicrobial susceptibility testing, 20th information update, vol. 29. Clinical Laboratory Standards Institute, Wayne, PA.
12. Cody, V., J. Pace, K. Chisum, and A. Rosowsky. 2006. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions. Proteins 65:959-969.
13. Dale, G. E., D. Broger, A. D'Arcy, P. G. Hartman, R. DeHoogt, S. Jolidon, I. Kompis, A. M. Labhardt, H. Langen, H. Locher, M. G. Page, D. Stüber, R. L. Then, B. Wipf, and C. Oefner. 1997. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. J. Mol. Biol. 266:23-30.
14. Dale, G. E., H. Langen, M. G. P. Page, R. L. Then, and D. Stüber. 1995. Cloning and characterization of a novel, plasmid-encoded trimethoprim-resistant dihydrofolate reductase from Staphylococcus haemolyticus MUR313. Antimicrob. Agents Chemother. 39:1920-1924.
15. Dibbern, D. A., Jr., and A. Montanaro. 2008. Allergies to sulfonamide antibiotics and sulfur-containing drugs. Ann. Allergy Asthma Immunol. 100: 91-100.
16. Emsley, P., and K. Cowtan. 2004. COOT: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132.
17. Evans, P. 2006. Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62:72-82.
18. Fischbach, M. A., and C. T. Walsh. 2009. Antibiotics for emerging pathogens. Science 325:1089-1093.
19. Frey, K. M., J. Liu, M. N. Lombardo, D. B. Bolstad, D. L. Wright, and A. C. Anderson. 2009. Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance. J. Mol. Biol. 387:1298-1308.
20. Frey, K. M., M. N. Lombardo, D. L. Wright, and A. C. Anderson. 2010. Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase. J. Struct. Biol. 170:93-97.
21. Grim, S. A., R. P. Rapp, C. A. Martin, and M. E. Evans. 2005. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. Pharmacotherapy 25:253-264.
22. Heaslet, H., M. Harris, K. Fahnoe, R. Sarver, H. Putz, J. Chang, C. Subramanyam, G. Barreiro, and J. R. Miller. 2009. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim. Proteins 76:706-717.
23. Keiser, M. J., V. Setola, J. J. Irwin, C. Laggner, A. I. Abbas, S. J. Hufeisen, N. H. Jensen, M. B. Kuijer, R. C. Matos, T. B. Tran, R. Whaley, R. A. Glennon, J. Hert, K. L. Thomas, D. D. Edwards, B. K. Shoichet, and B. L. Roth. 2009. Predicting new molecular targets for known drugs. Nature 462: 175-181.
24. Leslie, A. G. W. 1992. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 ESF-EAMCB Newslett. Protein Crystallogr., no. 26.
25. McCoy, A. J., R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, and R. J. Read. 2007. Phaser crystallographic software. J. Appl. Crystallogr. 40:658-674.
26. Oefner, C., M. Bandera, A. Haldimann, H. Laue, H. Schulz, S. Mukhija, S. Parisi, L. Weiss, S. Lociuro, and G. E. Dale. 2009. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity. J. Antimicrob. Chemother. 63:687-698.
27. Oefner, C., S. Parisi, H. Schulz, S. Lociuro, and G. E. Dale. 2009. Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus. Acta Crystallogr. D Biol. Crystallogr. 65:751-757.
28. Painter, J., and E. A. Merritt. 2006. Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol. Crystallogr. 62:439-450.
29. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, and T. E. Ferrin. 2004. UCSF Chimera: a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
30. Powell, J. P., and R. P. Wenzel. 2008. Antibiotic options for treating community-acquired MRSA. Expert Rev. Anti Infect. Ther. 6:299-307.
31. Schneider, P., S. Hawser, and K. Islam. 2003. Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria. Bioorg. Med. Chem. Lett. 13:4217-4221.
32. Sobolev, V., A. Sorokine, J. Prilusky, E. E. Abola, and M. Edelman. 1999. Automated analysis of interatomic contacts in proteins. Bioinformatics (Oxford) 15:327-332. (Pubitemid 29213759)
33. Zinner, S. H. 2007. Antibiotic use: present and future. New Microbiol. 30:321-325.